Enveric Biosciences (ENVB) vs Imunon (IMNN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Enveric Biosciences is the larger company by market cap ($6.7 million vs $6.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ENVB | IMNN |
|---|---|---|
| Share price | $1.49 | $1.08 |
| Market cap | $6.67M | $6.03M |
| 1-day change | -0.33% | -4.02% |
| EPS (TTM) | $-13.01 | $-3.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.25 | $5.39 |
| 52-week low | $1.17 | $1.04 |
| Distance from 52-week high | -88.75% | -80.06% |
| Average volume | 103.09K | 153.67K |
| Shares outstanding | 4.48M | 5.61M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ENVB vs IMNN FAQ
Which is bigger, Enveric Biosciences or Imunon?
Enveric Biosciences (ENVB) is larger, with a market capitalization of $6.67M compared with $6.03M for Imunon (IMNN).
Are Enveric Biosciences and Imunon in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.